go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Arkansas rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much rates vary

Facilitymedian $575,440 · 10th to 90th $575,440 to $691,831Professionalmedian $691,831 · 10th to 90th $575,440 to $691,831
facility $575,440professional $691,831

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$691,830.97
Median
$691,830.97
Typical High
$691,830.97
Aetna
Setting
Professional
Modifier
None
Typical Low
$575,439.94
Median
$691,830.97
Typical High
$691,830.97
Aetna
Setting
Professional
Modifier
52 · Reduced service
Typical Low
$288,403.15
Median
$346,736.85
Typical High
$346,736.85
Aetna
Setting
Professional
Modifier
53 · Discontinued
Typical Low
$114,815.36
Median
$138,038.43
Typical High
$138,038.43
Aetna
Setting
Professional
Modifier
55 · Aftercare only
Typical Low
$87,096.36
Median
$104,712.85
Typical High
$104,712.85
Aetna
Setting
Professional
Modifier
56 · Pre-op care only
Typical Low
$57,543.99
Median
$69,183.10
Typical High
$69,183.10
United
Setting
Facility
Modifier
None
Typical Low
$575,439.94
Median
$575,439.94
Typical High
$575,439.94
United
Setting
Professional
Modifier
None
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$645,654.23